Laura Lande-Diner, PhD

Laura Lande-Diner, PhD, is a biotech entrepreneur, investor, and operating executive with extensive experience building and scaling innovative life sciences companies. As Managing Partner of Jefferson Life Sciences, the life sciences investment arm of Jefferson River Capital, she invests in companies advancing transformative innovations in medicine. Laura brings a unique combination of scientific expertise, operating leadership, and strategic investment experience.

Previously Laura was a founding executive at Satellite Bio, serving as Chief Business Officer and later President. She was also a founding team member at Valo Health, where she helped shape early strategy, led data strategy, and executed foundational business development partnerships. In addition, Laura was part of the Origination team at Flagship Pioneering, where she contributed to the founding and early development of four life sciences companies.

Laura earned her PhD in Epigenetics and Molecular Biology from the Hebrew University of Jerusalem Medical School and completed postdoctoral research in Circadian Biology at Harvard Medical School, where she later served as an Instructor in Neurobiology. She currently serves on the Museum of Science, Boston, Board of Trustees.